A device in clinical development appears to be far safer and more effective than the TAVI devices currently being used ...

iRhythm Technologies announced results from two large, real-world analyses demonstrating the benefits of its Zio system. The retrospective analyses drew on data from more than 1.1 million patients ...

JenaValve Technology, Inc. IRVINE, Calif. and CHICAGO, March 31, 2025 (GLOBE NEWSWIRE) -- JenaValve Technology, Inc., developer and manufacturer of the Trilogy™ Transcatheter Heart Valve (THV ...

The Trilogy valve. [Image from the JenaValve website] JenaValve today announced new results from an expanded cohort receiving its Trilogy transcatheter heart valve (THV) system. The ALIGN-AR ...

Patients enrolled at 28 U.S. sites between 2018 and 2024 with moderate-to-severe or severe symptomatic aortic regurgitation underwent TAVR with the JenaValve Trilogy transcatheter heart valve. Total ...

The Heart Valve Devices Market is witnessing a transformative phase as cardiovascular diseases (CVDs) continue to top the global mortality chart. With an aging population, lifestyle changes, and ...